FDA Adverse Event Injury Summary report: N

DEEP BRAIN STIMULATION LEAD

MDR report key: 939950 · Received November 7, 2007

Report

Report Number
2182207-2007-03716
Event Type
Injury
Date Received
November 7, 2007
Report Date
October 14, 2007
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

JOURNAL REFERENCE: BALASH ET AL. "SUICIDAL THOUGHTS IN PATIENTS WITH PARKINSON'S DISEASE TREATED BY DEEP BRAIN STIMULATION OF THE SUBTHALAMIC NUCLEI: TWO CASE REPORTS AND REVIEW OF THE LITERATURE" ACTA NEUROPSYCHIATRICA 2007:19:3: 208-210.

Description of Event or Problem · 1

JOURNAL REFERENCE: BALASH ET AL. "SUICIDAL THOUGHTS IN PATIENTS WITH PARKINSON'S DISEASE TREATED BY DEEP BRAIN STIMULATION OF THE SUBTHALAMIC NUCLEI: TWO CASE REPORTS AND REVIEW OF THE LITERATURE" ACTA NEUROPSYCHIATRICA 2007:19:3: 208-210. TWO PATIENTS WITH SERIOUS LIFE-THREATENING DEPRESSIVE EPISODES ARE DESCRIBED. A FEMALE PATIENT WITH A HISTORY OF PARKINSON'S DISEASE, TREMOR, RIGIDITY, DYSKINESIAS, AKINESIA AND LEG DYSTONIA WAS SUCCESSFULLY TREATED WITH DBS. SIGNIFICANT MOTOR SKILL IMPROVEMENT WAS OBSERVED. SOME DYSPHASIC DYSKINESIA WAS NOTED TWO MONTHS POST-OP THOUGHT TO BE RELATED TO OVERSTIMULATION OF THE LEFT STN ELECTRODE. NON-INVASIVE ADJUSTMENTS (DECREASE) OF THE STIMULATION LEVEL CORRECTED THE DYSKINESIA. FOLLOWING THE ADJUSTMENT THE PATIENT'S DYSKINESIA WAS IMPROVED BUT WITHIN 24 HOURS SHE EXPERIENCED SEVERE AND PERSISTENT DEPRESSION SYMPTOMS WITH SUICIDAL THOUGHTS. SHE WAS HOSPITALIZED IN THE PSYCHIATRIC CLINIC AND TREATED WITH FLUOXETINE AND VENLAFAXINE. RESTARTING LEVODOPA (500 MG/DAY) RESOLVED THE DEPRESSION SYMPTOMS IN A FEW HOURS. FOLLOW-UP AT ONE YEAR FOUND THE PATIENT ON A SMALL DOSAGE OF LEVODOPA WITH NO DEPRESSION SYMPTOMS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DEEP BRAIN STIMULATION LEAD MHY MEDTRONIC NEUROMODULATION UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 48 YR Hospitalization| R